ACERINOX: FY2025 RESULTS AND T.P. INCREASE (ANÁLISIS BANCO SABADELL)
4Q'25 vs. 4Q'24 Results
Sales: € 1.31 Bn (-1.3% vs. -24.1% BS(e) and -18.8% consensus);
EBITDA: € 32 M (-78.7% vs. +116.6% BS(e) and +80.2% consensus);
EBIT: € -23 M (116 M in 4Q'24 vs. 10 M BS(e) and 17 M consensus);
Net Profit: € -47 M (€ 63 M in 4Q’24 vs. -15 M BS(e) and 17 M consensus);
2025 vs. 2024 Results
Sales: € 5.78 Bn (+6.8% vs. +8.4% BS(e) and +6.2% consensus);
EBITDA: € 354 M (-29.2% vs. -23.6% BS(e) and -20.0% consensus);
EBIT: € 153 M (-56.0% vs. -46.6% BS(e) and -44.5% consensus);
Net Profit: € -40 M (225 M in 2024 vs. -8 M BS(e) and 24 M consensus).